Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?
Objective It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease. Methods Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections. Results Serum concentrati...
Saved in:
Published in | Inflammation research Vol. 58; no. 8; pp. 503 - 512 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
SP Birkhäuser Verlag Basel
01.08.2009
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1023-3830 1420-908X 1420-908X |
DOI | 10.1007/s00011-009-0016-8 |
Cover
Summary: | Objective
It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease.
Methods
Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections.
Results
Serum concentrations were significantly increased in specimen of patients with active and remission-stage ulcerative colitis and Crohn’s disease, associated with emerging positivity of CD14
+
cells.
Conclusion
Enhanced concentration of galectin-3 in serum reflects presence of disease and points to its involvement in the pathogenesis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1023-3830 1420-908X 1420-908X |
DOI: | 10.1007/s00011-009-0016-8 |